Genelux (GNLX) EBITDA Margin (2022 - 2024)

Genelux (GNLX) has 3 years of EBITDA Margin data on record, last reported at 101437.5% in Q1 2024.

  • For Q1 2024, EBITDA Margin fell 9763632.0% year-over-year to 101437.5%; the TTM value through Sep 2024 reached 354250.0%, down 34573824.0%, while the annual FY2023 figure was 14214.71%, 1418748.0% down from the prior year.
  • EBITDA Margin reached 101437.5% in Q1 2024 per GNLX's latest filing, down from 3801.18% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 3801.18% in Q1 2023 and bottomed at 101437.5% in Q1 2024.
  • Average EBITDA Margin over 3 years is 36596.23%, with a median of 4550.0% recorded in 2022.
  • The widest YoY moves for EBITDA Margin: up -9763632bps in 2024, down -9763632bps in 2024.
  • A 3-year view of EBITDA Margin shows it stood at 4550.0% in 2022, then increased by 16bps to 3801.18% in 2023, then crashed by -2569bps to 101437.5% in 2024.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 101437.5% in Q1 2024, 3801.18% in Q1 2023, and 4550.0% in Q4 2022.